Drug recalls

748 recalls.

• Atorvastatin Calcium Tablets recall (MSN Laboratories Private Limited (Formulations Division, Unit-II))
  DrugClass IIReported November 4, 2026 · Presence of Foreign Tablets/Capsules
• Theophylline Extended-Release Tablets recall (Brandywine Pharmaceuticals, LLC)
  DrugClass IIReported November 4, 2026 · CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory
• Theophylline Extended-Release Tablets recall (Brandywine Pharmaceuticals, LLC)
  DrugClass IIReported November 4, 2026 · CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory
• Vecuronium Bromide for Injection recall (Meitheal Pharmaceuticals, Inc)
  DrugClass IIIReported November 4, 2026 · Labeling: Label Lacks Warning or Rx Legend
• Vecuronium Bromide for Injection recall (Meitheal Pharmaceuticals, Inc)
  DrugClass IIIReported November 4, 2026 · Labeling: Label Lacks Warning or Rx Legend
• Lidocaine Ointment USP recall (Direct Rx)
  DrugClass IIReported November 4, 2026 · Subpotent Drug
• OXYTOCIN recall (Eagle Pharma Outsourcing LLC)
  DrugClass IIReported November 4, 2026 · Lack of Assurance of Sterility
• PHENYLephrine HCL Infusion recall (Eagle Pharma Outsourcing LLC)
  DrugClass IIReported November 4, 2026 · Lack of Assurance of Sterility
• ULTRA STRENTGH recall (Fei Fah Medical Manufacturing Pte. Ltd.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• Wechem Hand Guard8/1000mL Bag recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• SunCoast Paper Inc. Surgent Antiseptic Hand Soap recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• Spurrier recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• Chemseptic recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• Pro Chem Suds Hand Soap recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• PRO CHEM BAN AID recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• PRO CHEM Fresh Start recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• People's FM-24 FOAMING High Foaming Antiseptic Hand and Body Wash recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• Handtastic Foamy Mango Antiseptic Foam Soap Hand & Body Wash recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• Lynx recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• Lynx recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• Lynx recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• Antiseptic Hand Soap recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• Delta Foremost Sani-Foam Mango recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• Freshhands Premium Foamy Antibacterial Hand Soap Antiseptic recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• Certus Medical Satin Foam recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• Aero Foamy Mango Aloe Vera Antiseptic Hand & Body Wash recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• Aerocare Sani Mango Antiseptic Hand and Body Wash recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• Palm Antiseptic Hand Soap Net Contents: 1 Gallon recall (ABC Compounding Co., Inc.)
  DrugClass IIReported November 4, 2026 · CGMP Deviations
• ValuHealth Extra Strength Pain Relief Acetaminophen 500 mg recall (Prodose, Inc.)
  DrugClass IIIReported November 4, 2026 · Incorrect label placed on product: Outer carton label correctly identifies drug product in bottle as ValuHealth Extra Strength Pain Relief Acetaminophen 500...
• Carboxymethylcellulose Sodium recall (Huons Co., Ltd.)
  DrugClass IIReported November 4, 2026 · Failed Impurities/Degradation Specification; detection of polyethylene (PE)-related oligomers
• Olmesartan Medoxomil recall (MACLEODS PHARMA USA, INC)
  DrugClass IIReported November 4, 2026 · Failed Dissolution Specifications.
• Metoclopramide Tablets recall (Safecor Health, LLC)
  DrugClass IIReported November 4, 2026 · Manufacturer is recalling batches due to co-mingled tablet.
• Abiraterone Acetate Tablets USP 500 mg recall (Glenmark Pharmaceuticals Inc., USA)
  DrugClass IIReported November 4, 2026 · Labeling: Not Elsewhere Classified
• Formoterol Fumarate Inhalation Solution recall (The Ritedose Corporation)
  DrugClass IIReported November 4, 2026 · Failed Impurities/Degradation Specification
• Glutathione Injection recall (Greenwich Rx)
  DrugClass IReported October 28, 2026 · Microbial Contamination of Sterile Products
• Argatroban Injection recall (Par Health USA, LLC)
  DrugClass IReported October 28, 2026 · Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product...
• Argatroban Injection recall (Par Health USA, LLC)
  DrugClass IReported October 28, 2026 · Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product...
• Cinacalcet Tablets recall (STRIDES PHARMA INC)
  DrugClass IIReported October 28, 2026 · Failed dissolution specifications
• Abirtega recall (Hikma Pharmaceuticals USA INC.)
  DrugClass IIReported October 28, 2026 · Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
• Testosterone Cypionate recall (Right Value Drug Stores LLC)
  DrugClass IIReported October 28, 2026 · Lack of sterility assurance.
• ARU recall (PRITAM INTERNATIONAL PRIVATE LIMITED)
  DrugClass IIReported October 28, 2026 · CGMP Deviations.
• ARU recall (PRITAM INTERNATIONAL PRIVATE LIMITED)
  DrugClass IIReported October 28, 2026 · CGMP Deviations.
• BB recall (PRITAM INTERNATIONAL PRIVATE LIMITED)
  DrugClass IIReported October 28, 2026 · CGMP Deviations.
• BB recall (PRITAM INTERNATIONAL PRIVATE LIMITED)
  DrugClass IIReported October 28, 2026 · CGMP Deviations.
• Brush Buddies recall (PRITAM INTERNATIONAL PRIVATE LIMITED)
  DrugClass IIReported October 28, 2026 · CGMP Deviations.
• Brush Buddies recall (PRITAM INTERNATIONAL PRIVATE LIMITED)
  DrugClass IIReported October 28, 2026 · CGMP Deviations.
• Brush Buddies recall (PRITAM INTERNATIONAL PRIVATE LIMITED)
  DrugClass IIReported October 28, 2026 · CGMP Deviations.
• Brush Buddies recall (PRITAM INTERNATIONAL PRIVATE LIMITED)
  DrugClass IIReported October 28, 2026 · CGMP Deviations.
• Brush Buddies recall (PRITAM INTERNATIONAL PRIVATE LIMITED)
  DrugClass IIReported October 28, 2026 · CGMP Deviations
• evo recall (PRITAM INTERNATIONAL PRIVATE LIMITED)
  DrugClass IIReported October 28, 2026 · CGMP Deviations.
• evo recall (PRITAM INTERNATIONAL PRIVATE LIMITED)
  DrugClass IIReported October 28, 2026 · CGMP Deviations.
• Brush Buddies recall (PRITAM INTERNATIONAL PRIVATE LIMITED)
  DrugClass IIReported October 28, 2026 · CGMP Deviations.
• Brush Buddies recall (PRITAM INTERNATIONAL PRIVATE LIMITED)
  DrugClass IIReported October 28, 2026 · CGMP Deviations.
• Brush Buddies recall (PRITAM INTERNATIONAL PRIVATE LIMITED)
  DrugClass IIReported October 28, 2026 · CGMP Deviations.
• Brush Buddies recall (PRITAM INTERNATIONAL PRIVATE LIMITED)
  DrugClass IIReported October 28, 2026 · CGMP Deviations
• Brush Buddies recall (PRITAM INTERNATIONAL PRIVATE LIMITED)
  DrugClass IIReported October 28, 2026 · CGMP Deviations.
• Brush Buddies recall (PRITAM INTERNATIONAL PRIVATE LIMITED)
  DrugClass IIReported October 28, 2026 · CGMP Deviations
• Levoxyl recall (Pfizer)
  DrugClass IIReported October 28, 2026 · Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
• Levoxyl recall (Pfizer)
  DrugClass IIReported October 28, 2026 · Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
• Heparin Sodium Injection recall (Shenzhen Techdow Pharmaceutical Co., Ltd.)
  DrugClass IIReported October 28, 2026 · Lack of Assurance of Sterility
• Telmisartan and Amlodipine recall (Viatris, Inc.)
  DrugClass IIIReported October 28, 2026 · Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications
• Amlodipine and Olmesartan Medoxomil Tablets recall (Ascend Laboratories, LLC)
  DrugClass IIReported October 28, 2026 · Out of specification due to dissolution.
• Metoclopramide Tablets recall (American Health Packaging)
  DrugClass IIReported October 21, 2026 · Presence of Foreign Tablets/Capsules
• Sermorelin recall (Houston Rx LLC)
  DrugClass IIReported October 21, 2026 · Lack of process control
• Tirzepatide/Niacinamide 2mL vial recall (Houston Rx LLC)
  DrugClass IIReported October 21, 2026 · Lack of assurance of sterility.
• Hydrocortisone Sodium Succinate for Injection recall (Zydus Pharmaceuticals (USA) Inc)
  DrugClass IIReported October 21, 2026 · Failed Impurities/Degradation Specifications.
• Metoclopramide Tablets recall (Teva Pharmaceuticals USA, Inc)
  DrugClass IIReported October 21, 2026 · Presence of Foreign Tablets/Capsules
• Tri-Immune Boost recall (Centric Compounding LLC)
  DrugNot Yet ClassifiedReported October 14, 2026 · Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
• Apothecary NAD+ Injection 200 mg/mL recall (Apothecary Pharma LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility
• Tirzepatide Injection recall (Apothecary Pharma LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility
• Tretinoin Cream UPS recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIIReported October 14, 2026 · Failed Impurities/Degradation Specifications
• Tretinoin Cream USP recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIIReported October 14, 2026 · Failed Impurities/Degradation Specifications
• Tretinoin Cream USP recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIIReported October 14, 2026 · Failed Impurities/Degradation Specifications
• Tri-MIX recall (Carolina Infusion, LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
• Tri-MIX recall (Carolina Infusion, LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
• TIRZEPATIDE/CYANOCOBALAMIN 85/2 MG/ML INJECTABLE recall (Carolina Infusion, LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
• TIRZEPATIDE/CYANOCOBALAMIN 76/2 MG/ML INJECTABLE recall (Carolina Infusion, LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
• TIRZEPATIDE/CYANOCOBALAMIN 64/2 MG/ML INJECTABLE recall (Carolina Infusion, LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
• TIRZEPATIDE/CYANOCOBALAMIN 26/2 MG/ML INJECTABLE recall (Carolina Infusion, LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
• SEMAGLUTIDE/CYANOCOBALAMIN 9/2 MG/ML INJECTABLE recall (Carolina Infusion, LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
• Tri-MIX recall (Carolina Infusion, LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
• Tri-MIX recall (Carolina Infusion, LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
• Tri-MIX recall (Carolina Infusion, LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
• Tri-MIX recall (Carolina Infusion, LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
• QUAD-MIX recall (Carolina Infusion, LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
• SERMORELIN ACETATE 1 MG/ML INJECTABLE recall (Carolina Infusion, LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
• SEMAGLUTIDE/CYANOCOBALAMIN 3/2 MG/ML INJECTABLE recall (Carolina Infusion, LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
• SEMAGLUTIDE 3 MG/ML INJECTABLE recall (Carolina Infusion, LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
• TIRZEPATIDE 26 MG/ML INJECTABLE recall (Carolina Infusion, LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
• IMAAVY recall (J&J INNOVATIVE MEDICINE)
  DrugClass IIReported October 14, 2026 · Presence of particulate matter.
• Fosfomycin Tromethamine Granules for Oral Solution recall (Cipla USA, Inc.)
  DrugClass IIReported October 14, 2026 · Failed Impurities/Degradation Specifications
• Lidocaine Ointment USP recall (Preferred Pharmaceuticals, Inc.)
  DrugClass IIReported October 14, 2026 · Failed Content Uniformity Specifications
• Biospectra Tris/Tromethamine recall (BioSpectra, Inc.)
  DrugClass IIReported October 14, 2026 · Failed stability specifications
• Sterile High Performance Ultra Lubricating Eye Drops recall (K.C. Pharmaceuticals, Inc.)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility
• Sterile Eye Drops Redness Relief recall (K.C. Pharmaceuticals, Inc.)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility
• Sterile Eye Drops recall (K.C. Pharmaceuticals, Inc.)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility
• Sterile Lubricant Dry Eye Relief Eye Drops recall (K.C. Pharmaceuticals, Inc.)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility
• Eye Drops MAXIMUM recall (K.C. Pharmaceuticals, Inc.)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility
• Sterile EYE DROPS Advanced Relief recall (K.C. Pharmaceuticals, Inc.)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility
• Sterile EYE DROPS AC recall (K.C. Pharmaceuticals, Inc.)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility

Older →